N-Acetyl Selank Amidate vs PE-22-28 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
N-Acetyl Selank Amidate is a doubly-modified form of Selank (a synthetic heptapeptide based on tuftsin) with N-acetylation at the N-terminus and amidation at the C-terminus. These modifications extend enzymatic stability and CNS bioavailability, making it the highest-potency form...
Calculate N-Acetyl Selank Amidate dose →PE-22-28 is a synthetic fragment of spadin (a naturally occurring peptide derived from the NTSR3/sortilin propeptide) that antagonizes TREK-1, a two-pore domain potassium channel (K2P channel) that regulates neuronal excitability. TREK-1 is strongly implicated in depression and c...
Calculate PE-22-28 dose →| Parameter | N-Acetyl Selank Amidate | PE-22-28 |
|---|---|---|
| Category | Cognitive & Neurological | Cognitive & Neurological |
| Research | Research Use | Preclinical |
| Half-Life | ~6–8 hours (estimated; extended vs. standard Selank) | - |
| Typical Dose | 100–300 µg | 100–200 µg |
| Frequency | Once or twice daily | Daily |
| Route | Intranasal | Subcutaneous / Intranasal |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.